These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2000871)

  • 1. Visual compatibility of morphine sulfate and meperidine hydrochloride with other injectable drugs during simulated Y-site injection.
    Pugh CB; Pabis DJ; Rodriguez C
    Am J Hosp Pharm; 1991 Jan; 48(1):123-5. PubMed ID: 2000871
    [No Abstract]   [Full Text] [Related]  

  • 2. Compatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administration.
    Karnatz NN; Wong J; Kesler H; Baaske DM; Speicher ER
    Am J Hosp Pharm; 1988 Feb; 45(2):368-71. PubMed ID: 2896460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of labetalol hydrochloride with selected critical care drugs during simulated Y-site injection.
    Hassan E; Leslie J; Martir-Herrero ML
    Am J Hosp Pharm; 1994 Sep; 51(17):2143-5. PubMed ID: 7985689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of morphine sulfate and meperidine hydrochloride in a parenteral nutrient formulation.
    Macias JM; Martin WJ; Lloyd CW
    Am J Hosp Pharm; 1985 May; 42(5):1087-94. PubMed ID: 3923832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility and stability of ondansetron hydrochloride with morphine sulfate and with hydromorphone hydrochloride in 0.9% sodium chloride injection at 4, 22, and 32 degrees C.
    Trissel LA; Xu Q; Martinez JF; Fox JL
    Am J Hosp Pharm; 1994 Sep; 51(17):2138-42. PubMed ID: 7527184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual compatibility of labetalol hydrochloride injection with various injectable drugs during simulated Y-site injection.
    Colucci RD; Cobuzzi LE; Halpern NA
    Am J Hosp Pharm; 1988 Jun; 45(6):1357-8. PubMed ID: 3414706
    [No Abstract]   [Full Text] [Related]  

  • 7. Compatibility of ondansetron hydrochloride with meperidine hydrochloride for combined administration.
    Xu QA; Trissel LA; Fox JL
    Ann Pharmacother; 1995 Nov; 29(11):1106-9. PubMed ID: 8573953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual compatibility of esmolol hydrochloride and various injectable drugs during simulated Y-site injection.
    Colucci RD; Cobuzzi LE; Halpern NA
    Am J Hosp Pharm; 1988 Mar; 45(3):630-2. PubMed ID: 2897164
    [No Abstract]   [Full Text] [Related]  

  • 9. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration.
    Lor E; Sheybani T; Takagi J
    Am J Hosp Pharm; 1991 Apr; 48(4):744-6. PubMed ID: 2042678
    [No Abstract]   [Full Text] [Related]  

  • 10. Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration.
    Baltz JK; Kennedy P; Minor JR; Gallelli J
    Am J Hosp Pharm; 1990 Sep; 47(9):2075-7. PubMed ID: 2145761
    [No Abstract]   [Full Text] [Related]  

  • 11. Visual compatibility of diltiazem with commonly used injectable drugs during simulated Y-site administration.
    Zanetti LA
    Am J Hosp Pharm; 1992 Aug; 49(8):1911. PubMed ID: 1442831
    [No Abstract]   [Full Text] [Related]  

  • 12. Compatibility of bupivacaine hydrochloride with hydromorphone hydrochloride or morphine sulfate.
    Neels JT
    Am J Hosp Pharm; 1992 Sep; 49(9):2149. PubMed ID: 1381871
    [No Abstract]   [Full Text] [Related]  

  • 13. Compatibility of magnesium sulfate and morphine sulfate in 0.9% sodium chloride injection.
    Vogt C; Skipper PM; Ruggaber S
    Am J Hosp Pharm; 1993 Nov; 50(11):2311. PubMed ID: 8266950
    [No Abstract]   [Full Text] [Related]  

  • 14. Visual compatibility of fentanyl citrate with selected drugs during simulated Y-site injection.
    Marquardt ED; Lam SS
    Am J Hosp Pharm; 1994 Mar; 51(6):811-2. PubMed ID: 8010323
    [No Abstract]   [Full Text] [Related]  

  • 15. Compatibility of verapamil hydrochloride with penicillin admixtures during simulated Y-site injection.
    Thompson DF; Stiles ML; Allen LV; Tu YH
    Am J Hosp Pharm; 1988 Jan; 45(1):142-5. PubMed ID: 3348228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of midazolam hydrochloride and morphine sulfate during simulated intravenous coadministration.
    Johnson CE; Bhatt-Mehta V; Mancari SC; McKown JA
    Am J Hosp Pharm; 1994 Nov; 51(22):2812-5. PubMed ID: 7856605
    [No Abstract]   [Full Text] [Related]  

  • 17. Visual compatibility of haloperidol lactate with 0.9% sodium chloride injection or injectable critical-care drugs during simulated Y-site injection.
    Outman WR; Monolakis J
    Am J Hosp Pharm; 1991 Jul; 48(7):1539-41. PubMed ID: 1882889
    [No Abstract]   [Full Text] [Related]  

  • 18. Visual compatibility of idarubicin hydrochloride with selected drugs during simulated Y-site injection.
    Turowski RC; Durthaler JM
    Am J Hosp Pharm; 1991 Oct; 48(10):2181-4. PubMed ID: 1781476
    [No Abstract]   [Full Text] [Related]  

  • 19. Visual compatibility of zidovudine with other injectable drugs during simulated Y-site administration.
    Bashaw ED; Amantea MA; Minor JR; Gallelli JF
    Am J Hosp Pharm; 1988 Dec; 45(12):2532-3. PubMed ID: 3228107
    [No Abstract]   [Full Text] [Related]  

  • 20. Additional data on visual compatibility of foscarnet sodium with morphine sulfate.
    DiStefano JE; Outman WR
    Am J Hosp Pharm; 1992 Jul; 49(7):1672. PubMed ID: 1535751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.